Market cap
$52 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
0.5
P/B Ratio
4.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -57.14 | -57.14 | 400.00 | -57.92 | -- |
| EBIT | 69.26 | 95.02 | 95.87 | 12.88 | -2.31 |
| Net Profit | 69.52 | 95.13 | 102.09 | 28.22 | 21.84 |
| EPS | 69.45 | 99.45 | 100.50 | 26.57 | 16.82 |
| Book Value | -- | -- | 8.00 | -46.22 | -34.42 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -14,841.42 | -14,836.05 | -4,411.43 | -42,678.13 | -1,461.39 |
| Net Margin
| -- | -- | 2,254.29 | -- | -- |
| Return on equity
| -107.94 | -72.81 | 6.86 | -140.36 | -167.62 |
| Return on Capital
| -67.08 | -46.63 | -- | -91.96 | -97.98 |
| Return on Assets
| -49.48 | -35.13 | 2.59 | -62.81 | -76.11 |
| Debt to Equity (x)
| -- | -- | 0.00 | -- | 2.08 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
--
|
-91.96
|
-97.98
|
-11.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
6.86
|
-140.36
|
-167.62
|
-15.83
|
|
Peer Median
|
-40.29
|
--
|
--
|
--
|
--
|
ROA
--
--
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
2.59
|
-62.81
|
-76.11
|
-9.52
|
|
Peer Median
|
-30.84
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
-4,411.43
|
-42,678.13
|
-1,461.39
|
-384.76
|
|
Peer Median
|
-82.21
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
2,254.29
|
-36,993.75
|
-1,525.34
|
-420.98
|
|
Peer Median
|
-89.88
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
0.00
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
400.00
|
-0.98
|
0.57
|
19.60
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
--
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
95.87
|
42.31
|
-497.33
|
46.55
|
|
Peer Median
|
-0.95
|
--
|
--
|
--
|
--
|
Net Profit Growth
--
--
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
102.09
|
52.09
|
-469.83
|
38.51
|
|
Peer Median
|
-7.19
|
--
|
--
|
--
|
--
|
EPS Growth
--
--
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
100.50
|
0.83
|
-4.70
|
0.39
|
|
Peer Median
|
14.43
|
--
|
--
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
111.77
|
--
|
--
|
--
|
|
Peer Median
|
-10.46
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
--
|
--
|
2.08
|
0.48
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
--
|
0.05
|
2.08
|
0.48
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
--
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
0.16
|
0.35
|
0.25
|
0.03
|
|
Peer Median
|
5.80
|
--
|
--
|
--
|
--
|
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
0.13
|
0.30
|
0.25
|
--
|
|
Peer Median
|
5.69
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
0.02
|
-17.22
|
-201.63
|
-8.93
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
562.86
|
634.38
|
11.36
|
32.14
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
0.00
|
0.00
|
0.05
|
0.02
|
|
Peer Median
|
0.07
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
--
|
2,208.62
|
58.06
|
61.53
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
--
|
27.02
|
-0.09
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
--
|
456.56
|
252.15
|
223.55
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
--
|
1,779.08
|
-194.17
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
0.55
|
--
|
-0.68
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
4.50
|
--
|
3.92
|
--
|
|
Peer Median
|
5.35
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
--
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
4.72
|
--
|
-0.96
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Impact BioMedical, Inc (IBO)
|
--
|
52
|
--
|
--
|
--
|
|
Peer Median
|
147
|
--
|
--
|
--
|
--
|